What Foghorn Therapeutics Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 0 | 0 |
| Total trades | 0 | 4 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 106,705 |
| Disposed | 0 | 106,705 |
| Net activity | +0 | +0 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Gottschalk Adrian | Chief Executive Officer | Apr 10 | Gift · G | +59,208 | — | — | 270,912 |
| Gottschalk Adrian | Chief Executive Officer | Apr 10 | Gift · G | −59,208 | — | — | 240,792 |
| Gottschalk Adrian | Chief Executive Officer | Apr 09 | Gift · G | +47,497 | — | — | 211,704 |
| Gottschalk Adrian | Chief Executive Officer | Apr 09 | Gift · G | −47,497 | — | — | 0 |
| Gottschalk Adrian | Chief Executive Officer | Apr 25 | Gift · G | +300,000 | — | — | 511,704 |
| Gottschalk Adrian | Chief Executive Officer | Apr 25 | Gift · G | −300,000 | — | — | 511,704 |
| Gottschalk Adrian | Chief Executive Officer | Apr 09 | Gift · G | +197,906 | — | — | 511,704 |
| Gottschalk Adrian | Chief Executive Officer | Apr 09 | Gift · G | −197,906 | — | — | 511,704 |
| Costa Carlos | Chief People Officer | Sep 23 | Open-market sale · S | −857 | $10.17 | −$8.72K | 0 |
| Costa Carlos | Chief People Officer | Sep 23 | Exercise / conversion · M | +857 | $3.72 | +$3.19K | 857 |
| Costa Carlos | Chief People Officer | Sep 20 | Open-market sale · S | −35,756 | $10.04 | −$359K | 0 |
| Costa Carlos | Chief People Officer | Sep 20 | Exercise / conversion · M | +35,756 | $3.72 | +$133K | 35,756 |
| Costa Carlos | Chief People Officer | Sep 18 | Open-market sale · S | −11,574 | $10.05 | −$116K | 0 |
| Costa Carlos | Chief People Officer | Sep 18 | Exercise / conversion · M | +11,574 | $3.72 | +$43.1K | 11,574 |
| Costa Carlos | Chief People Officer | Sep 17 | Open-market sale · S | −10,272 | $10.04 | −$103K | 0 |
| Costa Carlos | Chief People Officer | Sep 17 | Exercise / conversion · M | +10,272 | $3.72 | +$38.2K | 10,272 |
| Costa Carlos | Chief People Officer | Sep 16 | Open-market sale · S | −400 | $10.00 | −$4K | 0 |
| Costa Carlos | Chief People Officer | Sep 16 | Exercise / conversion · M | +400 | $3.72 | +$1.49K | 400 |
| Bellon Steven F. | Chief Scientific Officer | Sep 09 | Open-market sale · S | −20,000 | $9.50 | −$190K | 101,957 |
| Cavalie Fanny | Chief Strategy/Bus Ops Officer | Mar 11 | Open-market sale · S | −11,000 | $6.56 | −$72.1K | 75,992 |
Loading...
